Garnette Sophia 4
4 · International Stem Cell CORP · Filed Aug 21, 2018
Insider Transaction Report
Form 4
International Stem Cell CORPISCO.OB
Bakalova Sofya
Dir. of Legal Affairs & Oper.
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-08-20−3,556→ 11,111 totalExercise: $1.09Exp: 2027-02-10→ Common Stock (14,667 underlying) - Exercise/Conversion
Common Stock
2018-08-20$1.09/sh+3,556$3,876→ 3,823 total - Exercise/Conversion
Common Stock
2018-08-20$1.10/sh+5,748$6,323→ 9,571 total - Sale
Common Stock
2018-08-20$1.58/sh−9,304$14,700→ 267 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-20−5,748→ 54,252 totalExercise: $1.10Exp: 2027-05-31→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share.
- [F2]The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.
- [F3]The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months.